Anti-donovani

BIRAD - Research and Development Co. Ltd

Effective Nanoscale Targeted Anti-leishmania Drug and Technological Platform for Nano-medicine

By Assaf Sagiv / December 17, 2020 / Comments Off on Effective Nanoscale Targeted Anti-leishmania Drug and Technological Platform for Nano-medicine

Leishmaniasis is a vector-borne tropical disease that affects 88 countries worldwide. The causal agent is a parasitic protozoon, Leishmania ssp. Cutaneous leishmaniasis (CL), caused by L. major, L. mexicana, and visceral leishmaniasis caused by L. donovani, is one of the most important neglected tropical diseases. Available treatments are highly toxic, and the serious side effects…

Read More